Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120004) titled 'An exploratory study of vedotin-tovacitinib combined with toripalimab in EGFR-positive refractory advanced biliary tract malignancies' on March 6.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Sichuan University West China Hospital
Condition:
Malignant biliary tumor
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-01
Target Sample Size: Vibecotecotamab combined with Putilimab for the treatment of EGFR-positive refractory advanced biliary malignant tumors:44;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/sho...